Our scalable business model, ability to employ multiple deal structures, and diverse expertise make us a partner of choice for biotechnology and pharmaceutical companies seeking to accelerate and scale their development efforts.


Working With Us

We offer the potential for rapid advancement and value creation for your molecules with:

  • Our team of proven drug development experts
  • Single-minded focus on rapidly achieving clinically meaningful endpoints

  • Full and separate funding for each program

  • Flexible, fast and creative approach to transactions


Our Portfolio Strategy


We are assembling a carefully constructed portfolio of clinical candidates across a broad array of mechanisms and therapeutic targets.

Ultimately, we will license or sell those programs that reach clinical proof of concept in order to create value for our company and our partners. We are:

  • Seeking late preclinical stage through early Phase 2 programs
  • Data-driven, and require a thorough understanding of the biology, mechanism, and potential therapeutic differentiation before committing to a program
  • Rigorous and objective in our approach to drug development, incorporating interim analyses and milestones in order to de-risk our investments before major capital commitments are made

Our Flexible Partnering Model

Our strong capital base and unique long-term investment cycle allow us to be flexible and creative in our deal structure and financing.

Our expertise and operating flexibility means that we can thoroughly assess any development opportunity efficiently and be very responsive to potential partners.


Partner With Us

To initiate a partnering discussion, visit us at an upcoming event or email us at